Azarashvili T, Baburina Y, Grachev D, Krestinina O, Evtodienko Y, Stricker R, Reiser G. Calcium-induced permeability transition in rat brain mitochondria is promoted by carbenoxolone through targeting connexin43.
load induced PTP opening, as seen by sudden Ca 2ϩ efflux from the mitochondrial matrix and membrane potential collapse. In synaptic RBM, Cbx (1 M) facilitated the Ca 2ϩ -induced, cyclosporine A-sensitive PTP opening, while in nonsynaptic mitochondria the Cbx threshold concentration was higher. A well-known molecular target of Cbx is the connexin (Cx) family, gap junction proteins. Moreover, Cx43 was previously found in heart mitochondria and attributed to the preconditioning mechanism of protection. Thus, we hypothesized that Cx43 might be a target for Cbx in brain mitochondria. For the first time, we detected Cx43 by Western blot in RBM, but Cx43 was absent in RLM. Interestingly, two anti-Cx43 antibodies, directed against amino acids 252 to 270 of rat Cx43, abolished the Cbxinduced enhancement of PTP opening in total RBM and in synaptic mitochondria, but not in RLM. In total RBM and in synaptic mitochondria, PTP caused dephosphorylation of Cx43 at serine 368. The phosphorylation level of serine 368 was decreased at threshold calcium concentration and additionally in the combined presence of Cbx in synaptic mitochondria. In conclusion, active mitochondrial Cx43 appears to counteract the Ca 2ϩ -induced PTP opening and thus might inhibit the PTP-ensuing mitochondrial demise and cell death. Consequently, we suggest that activity of Cx43 in brain mitochondria represents a novel molecular target for protection. permeability transition pore; liver mitochondria; neuroprotection LICORICE IS A WELL-KNOWN HERBAL remedy with antiinflammatory, antibacterial, antiviral, anticancer, and interferon-inducing activity (1) . One of the main constituents of medicinal licorice root is glycyrrhizic acid, which can be hydrolyzed to form 18␤-glycyrrhetinic acid (18␤-GA). The water-soluble succinyl ester of glycyrrhetinic acid, a 3-hemisuccinate derivative of glycyrrhetinic acid, is called carbenoxolone (Cbx). Cbx is well established in treatment for gastric ulcers, polyarthritis, and rheumatoid arthritis (1) . This compound is a drug licensed in the United Kingdom for esophageal ulceration and inflammation.
Both 18␤-GA and Cbx have been shown to affect mitochondrial function by inducing the opening of the mitochondrial permeability transition pore (PTP) in rat liver mitochondria (RLM), resulting in matrix swelling, collapse of the membrane potential, and release of cytochrome c. Cyclosporine A (CsA) abolished these effects of Cbx, including reactive oxygen species (ROS) formation, indicating that Cbx induces PTP opening through the generation of oxidative stress (16, 36, 37) . The authors suggested that the mechanism of Cbx-activated PTP opening is oxidative stress, which is produced by interacting with the mitochondrial respiratory chain at the level of complex I and complex III (36, 37) . However, the exact composition of PTP is not yet established (27) and the participation of complexes I and III in PTP function are under discussion (7, 20, 23, 44) . Therefore, the exact molecular targets of 18␤-GA and Cbx in the mitochondria were not yet identified.
A well-known target of Cbx is the connexin family of proteins, which form gap junction megachannels that mediate intercellular communication (21) . The function of connexins is regulated by phosphorylation, exerted by numerous protein kinases, including protein kinase A, protein kinase C, mitogenactivated protein kinase, and Src tyrosine kinase (12, 35, 39, 41, 42) . In accord with their function, the connexins are present in the plasma membrane. However, the carboxyl terminus of connexin43 (Cx43, 43 kDa) was found in cardiomyocyte nuclei (13) . For the first time, the mitochondrial localization of Cx43 was demonstrated for endothelial cells (28) . Additionally, Cx43 was detected in mitochondria of mouse, rat, pig, and human myocardium, using several techniques, such as immunoelectron microscopy, confocal microscopy, and Western blot analysis (19, 32, 34) . It has been reported that Cx43 plays a critical role in cardiac protection during ischemic and pharmacological preconditioning, and this role is independent from gap junction-mediated communication (9, 32, 34, 38) . In heart, the role of mitochondrial Cx43 in preconditioning appears to be related to signaling via ROS, but the molecular mechanism of action is still unclear. In heart mitochondria, Cx43 was detected mainly in the inner membranes and also in outer membranes as well as in contact sites (10, 14, 19) . There are no data yet on the existence of Cx43 in mitochondria from other tissues.
In the present study, we examined mitochondrial localization of Cx43 in brain and liver mitochondria. We previously discovered that several mitochondrial membrane-bound proteins in RLM and rat brain mitochondria (RBM) undergo changes in phosphorylation, depending on the PTP opening/ closing in the mitochondria (3, 4, 6) . Within these phosphoproteins, 43 -to 46-kDa proteins were discovered. Since Cx43 could be subjected to phosphorylation and Cx43 was already found in heart mitochondria, we hypothesized that Cx43 could be present in brain mitochondria and the effect of Cbx could be probably exerted through Cx43. This is the first report linking the effects of Cbx to the existence of Cx43 in mitochondria. Since mitochondria in brain are heterogeneous, we examined the effect of Cbx on total RBM, on synaptic and nonsynaptic mitochondria.
We show that Cbx enhances the Ca 2ϩ -induced PTP opening in RBM and RLM. In brain mitochondria, Cbx is more effective in synaptic than in nonsynaptic mitochondria. Moreover, we provide evidence that in brain, Cbx accelerates PTP opening by targeting Cx43, since a monoclonal antibody against Cx43 was able to abolish the Cbx-dependent acceleration of PTP opening in RBM, but not in RLM. In addition, the phosphorylation status of Cx43 was examined. A decrease in the level of the serine 368 phosphorylation of Cx43 in Ca 2ϩ -overloaded RBM was detected that was additionally lowered in the presence of Cbx in synaptic mitochondria. Other types of connexins, particularly Cx26 and Cx32, are revealed here for the first time in RLM.
MATERIALS AND METHODS

Materials and animals.
CsA, rotenone, oligomycin, carbenoxolone, bovine serum albumin (BSA; fatty acid free), Tris, N-acetylcysteine, and resveratrol were from Sigma. The following antibodies were used: mouse monoclonal anti-nonphospho(Ser368)Cx43 antibody (clone CX-1B1, detects Cx43 only when serine 368 is nonphosphorylated; catalog no. 13-8300), anti-Cx32 monoclonal antibody (clone 5 F9A9, catalog no. 35-8900), and anti-Cx26 monoclonal antibody (clone CX-1E8, catalog no. 33-5800) from Invitrogen (Karlsruhe, Germany); mouse monoclonal anti-Cx43 antibody [clone 2/Cx43 (aa 252-270), catalog no. 610062] from BD Biosciences (Becton-Dickinson, Heidelberg, Germany), for control comparison unrelated mouse and rabbit IgG (sc-2025 and sc-2027) from Santa Cruz (Heidelberg, Germany); rabbit polyclonal anti-phospho(Ser368)Cx43 antibody (catalog no. AB 3841), mouse anti-Cx43 [clone 4E6.2 (aa 252-270), catalog no. MAB3067] from Millipore (Schwalbach/Ts., Germany); polyclonal rabbit anti-porin antibody (AB-5, catalog no. PC548) from Calbiochem (Darmstadt, Germany); monoclonal mouse anti-cytochrome-c oxidase (COX; complex IV subunit IV) antibody (clone 20.E8C12, catalog no. MS407) from MitoSciences (Eugene, OR); monoclonal mouse anti-synaptotagmin I (clone Cl41.1, catalog no. 105 001) from Synaptic Systems (Göttingen, Germany). As secondary antibodies, horseradish peroxidase-conjugated goat anti-rabbit and goat anti-mouse antibodies (Dianova, Hamburg, Germany) were used.
Adult male Wistar rats (230 -250 g and 2-2.5 mo of age), which were used for obtaining tissues, were purchased from Harlan Winkelmann (Borchen, Germany). All animal procedures were approved by the ethics committee of the German federal state of Sachsen-Anhalt and were conducted in accordance with the European Community Council Directive (86/609/EEC).
Isolation of mitochondria from rat liver, heart, and brain. We isolated rat liver and heart mitochondria by differential centrifugation using standard protocols. Homogenization buffer consisted of 250 mM sucrose, 70 mM mannitol, 10 mM Tris·HCl (pH 7.4), 0.01% BSA, and 1 mM EGTA. BSA and EGTA were omitted from the wash solutions and from the final solution in which mitochondria were suspended. Final mitochondrial protein concentrations ranged from 60 to 65 mg/ml.
For isolation of RBM, the brain was immediately removed (within 30 s) and placed in ice-cold isolation buffer made up of 0.32 M sucrose, 0.5 mM EDTA, 0.5 mM EGTA, 0.2% BSA (fraction V), and 10 mM Tris·HCl (pH 7.4). The ratio of brain tissue to isolation medium was 1:10 (wt/vol). During tissue processing and mitochondrial isolation, all solutions were ice-cold, and all manipulations were carried out at 4°C. The tissue was disrupted in a glass homogenizer, and the homogenate was centrifuged at 2,000 g for 4 min. The resulting supernatant was centrifuged at 13,500 g for 10 min to obtain the RBM pellet. RBM were resuspended in a solution consisting of 0.32 M sucrose, 0.5 mM EDTA, 0.5 mM EGTA, 0.2% BSA (fraction V), and 10 mM Tris·HCl (pH 7.4). RBM were then washed in solution lacking BSA and EGTA. Twice-washed mitochondria without separation on Percoll gradient were used as total RBM. In the cases indicated in RESULTS, the pellet obtained after centrifugation at 13,500 g was purified on a Percoll gradient, similar to published procedures (40) . For that purification, the pellet was resuspended in 3% Percoll and applied on a previously prepared discontinuous Percoll gradient (10%, 15%, and 24%). This gradient was centrifuged at 36,500 g for 11 min. The upper band was the myelin fraction, the middle band was synaptic mitochondria (it should be noted that these mitochondria did not contain any contaminations by any other membranes, as demonstrated below), and the lower band was nonsynaptic mitochondria. In some cases, we used additional 40% Percoll layer, but we did not observe any fractions lower than nonsynaptic mitochondria. After Percoll density gradient, the synaptic and nonsynaptic mitochondria obtained were used for experiments.
For identification of Cx43 in mitochondrial pools, synaptic mitochondria were additionally purified taking the fraction obtained above. For that, after the Percoll gradient, the synaptic mitochondria fraction, which might have contained synaptosomes, was diluted with three volumes of isolation medium and spun down at 18,500 g for 10 min. The washed pellet was subjected to osmotic shock by homogenization with 5 ml of alkaline Tris medium (6 mM Tris·HCl, pH 8.1) with a glass homogenizer, according to the method of Lai and Clark (25) . An additional 10 ml of the alkaline Tris medium were gradually added to the latter homogenate with gentle mixing, followed by centrifugation at 11,800 g for 10 min. The pellet was resuspended in 5 ml of the alkaline Tris medium and homogenized by the same way. The pooled supernatants were centrifuged at 8,300 g for 10 min, and the pellet resuspended with 3% Percoll medium was layered onto a discontinuous Percoll gradient (7%; 14%) with centrifugation at 11,300 g for 30 min. The pellet was then resuspended in isolation medium without EDTA, EGTA, and BSA and centrifuged at 9,800 g for 10 min. These highly purified synaptic mitochondria were used for detection of Cx43 by Western blot.
Fractionation of RBM. Isolated RBM were subjected to fractionation by methods described previously (18) . Briefly, RBM were subjected to swelling by the addition of buffer (10 mM KH2PO4, pH 7.4) containing a cocktail of protease inhibitors and were incubated for 20 min at 4°C with gentle mixing. An equal volume of shrinking buffer (10 mM KH2PO4, pH 7.4, 32% sucrose, 30% glycerol, 10 mM MgCl2, and protease inhibitors) was added, and samples were incubated for an additional 20 min at 4°C. After centrifugation at 10,000 g for 10 min, the supernatant contained the outer membrane and the intermembrane space fractions, while the pellet comprised mitoplasts. The suspension of the outer membrane and intermembrane space fractions was centrifuged at 150,000 g for 1 h. Proteins from the intermembrane space fraction were concentrated using a Vivaspin 6 filter concentrator (Vivascience, Hannover, Germany) with a molecular mass cutoff of 10 kDa. The outer membranes and mitoplast pellets were solubilized in lysis buffer containing protease inhibitors, which are described above. The purity of the fraction was checked by Western blot analysis, using markers for the compartment-specific proteins as described before (18) . Membranes were stained by antivoltage-dependent anion channel (VDAC; porin) antibody (outer membrane), anti-cytochrome c antibody (intermembrane space), and anti-COX antibody (inner membrane), as well as anti-Mn-superoxide dismutase (SOD) antibody (mitoplasts).
Assessment of mitochondrial functions. The mitochondrial membrane potential (⌬⌿M), Ca 2ϩ transport, and oxygen consumption were measured in an open recording chamber, as described earlier (2) . ⌬⌿ M was determined by measurement of mitochondrial uptake of tetraphenylphosphonium (TPP ϩ ) using a TPP ϩ -selective electrode (Nico, Russia). Ca 2ϩ transport was determined with a Ca 2ϩ -sensitive electrode (Nico), and the oxygen consumption rate was determined with a Clark-type O2 electrode in a cell volume of 1 ml. Mitochondria (1 mg protein/ml) were incubated at 25°C in buffer containing 120 mM KCl, 10 mM Tris·HCl, 0.4 mM K2HPO4, 5 mM potassium succinate, and 5 M rotenone (pH 7.4). PTP opening was induced by supplementation of RBM suspensions with two or more additions of 60 -200 M Ca 2ϩ , depending on the type of mitochondria, as described elsewhere (2) . The monoclonal anti-Cx43 antibody (BectonDickinson) was used in experiments on the effects of the anti-Cx43 antibody on PTP function, as demonstrated in RESULTS. In the experiments, antibodies were preincubated with mitochondrial aliquots for 10 min at ϩ4°C at a ratio of 1 g antibody protein per 1 mg mitochondrial protein, followed by incubation in the chamber for 3 min at 25°C. In parallel, for control, another monoclonal anti-Cx43 antibody (corresponding to peptide position of 252-270 in the Cx43 sequence; Millipore) was also used in experiments showing similar effect (data not shown). Specificity of antibody action was checked taking an unrelated mouse IgG instead of anti-Cx43 antibody or BSA used at a concentration two times that of the anti-Cx43 antibody.
Swelling of RLM was measured as a change in light scattering of the mitochondrial suspension at 540 nm (A 540) using a Specord M-40 spectrophotometer at 30°C. Standard incubation medium for swelling assay contained 125 mM KCl, 10 mM Tris, 2 mM KH 2PO4, 10 mM succinate, and 0.5 M rotenone, pH 7.4. The concentration of protein in the cuvette was 0.5 mg/ml. The swelling was initiated by addition of 75 M Ca 2ϩ .
Identification of connexins in mitochondria by Western blotting.
For Western blot analysis, 30 g of mitochondrial protein was separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane. Two blots were prepared at the same time for parallel detection of phosphorylated and nonphosphorylated Cx43 under the same conditions as were used for the stripped membranes. Stripped membrane was used also for detection of VDAC or COX for normalization of Cx43 phosphorylation. Membranes were probed with mouse monoclonal anti-Cx43 antibody (1:1,000; Becton-Dickinson), antinonphospho(Ser368)Cx43 antibody (1:500; Invitrogen), rabbit polyclonal antiphospho(Ser368)Cx43 antibody (1:1,000; Millipore), anti-Cx32 monoclonal antibody (dilution 1:1,000; Invitrogen), and anti-Cx26 monoclonal antibody (dilution 1:1,000; Invitrogen). Horseradish peroxidase-conjugated secondary antibodies were used for detection of the immunocomplexes. Immunoreactions were developed using the SuperSignal West Pico and Femto detection system (Pierce, Rockford, IL).
Statistical analysis. Average semiquantitative data for the detection of phosphorylation status of Cx43 were obtained from three independent experiments, with samples of mitochondria isolated at different days, repeated three times in each experiment. The films were scanned with a reflectance densitometer (model GS-800, Bio-Rad) or the signals were directly detected by a ChemiDoc XRS molecular imager (Bio-Rad), and optical density values for each immunoreactive band were quantified with Quantity One program (version 4.4.1, Bio-Rad). All data are expressed as means Ϯ SD. Relative levels of phosphorylated proteins were compared using Student's t-test. A value of P Ͻ 0.05 was accepted as significant.
RESULTS
Effect of Cbx on parameters of PTP opening and respiration in RBM.
In the present study, we investigated for the first time the effect of Cbx on mitochondrial Ca 2ϩ accumulation and Ca 2ϩ -induced PTP opening in isolated RBM. First, we examined the effect of Cbx on induction of PTP in total RBM containing both populations, i.e., nonsynaptic and synaptic mitochondria. The simultaneously monitored membrane potential (⌬⌿ M ), which we determined by measuring the distribution of TPP ϩ in the same preparations, is shown in Fig. 1C . After the first addition of Ca 2ϩ , ⌬⌿ M sharply decreased, as indicated by an increase in the TPP ϩ concentration, but returned to the baseline level (Fig. 1C) . After the second Ca 2ϩ addition, an irreversible decrease in ⌬⌿ M occurred after the lag time. Inhibition of Ca 2ϩ uptake after the second Ca 2ϩ addition ( (Fig. 1B, traces [3] [4] [5] . In the presence of CsA, after two additions of Ca 2ϩ , neither in control RBM (not shown) nor in Cbx-treated RBM (Fig. 1C, trace 1 ) was a ⌬⌿ M dissipation observed, and no Ca 2ϩ efflux was seen (Fig. 1B , trace 1). The inhibition by CsA confirms that these effects could be attributed to the opening of the PTP. Respiration of RBM, which was also measured under the same conditions ( Fig. 1D) , was found to be altered in state 2 (V O2 st.2 ) in the presence of Cbx. Figure 1E gives the statistical analysis of the effects of Cbx in RBM. The state 2 (basal) oxygen consumption rate (V O2 st.2 ) was increased in a concentration-dependent manner with the application of Cbx. The summary in Fig. 1E also demonstrates that the Ca 2ϩ uptake rate after the second Ca 2ϩ pulse (V Ca2ϩ in.2 ) was decreased two times in the presence of 1 M Cbx and three times in the presence of 10 M Cbx. The lag time was decreased 2.5 times in the presence of 1 M Cbx, and about 10 times in the presence of 10 M Cbx (Fig. 1E) .
Effect of anti-Cx43 antibody on Cbx-stimulated PTP opening in RBM.
Because first, Cbx is a well-known gap junction blocking agent, and second, one of the connexins, Cx43, is present in heart mitochondria (9, 19, 32, 34) , we attempted here to clarify whether the ability of Cbx to stimulate PTP opening depends on targeting Cx43. In these experiments, we used two different monoclonal anti-Cx43 antibodies directed against a peptide covering amino acids 252 to 270 of rat Cx43.
When we compared traces 2 and 4 in Fig. 2 , A-C, to analyze the effect of the monoclonal anti-Cx43 antibody from BectonDickinson, we found that the anti-Cx43 antibody abolished the stimulatory effects of Cbx on Ca 2ϩ -induced PTP opening. The antibody prolonged the retention of calcium in the matrix and prevented the Cbx-induced acceleration of Ca 2ϩ efflux (compare Fig. 2A , traces 2 and 4) as well as dissipation of the membrane potential (compare Fig. 2B, traces 2 and 4) . To corroborate the observed effect, we also used another monoclonal anti-Cx43 antibody, which was from Millipore. Both antibodies displayed the same effect. Thus, Cx43 seems to participate in the modulation of the mitochondrial membrane permeability of RBM and appears to represent the target of Cbx. Figure 2D gives the statistical analysis of the effect of the anti-Cx43 antibody on the influence of Cbx in RBM. The state 2 ), which was reduced by Cbx, was again increased in the presence of the anti-Cx43 antibody in Cbx-treated RBM. Compared with Cbx-treated mitochondria, the lag time was increased three times in the presence of Cbx and anti-Cx43 antibody. The decrease in lag time caused by Cbx was completely restored by simultaneous addition of the anti-Cx43 antibody. Interestingly, preincubation of mitochondria with the anti-Cx43 antibody resulted in a small but significant increase of the lag time in the absence and presence of Cbx (ϳ20% above control value).
Appropriate controls for the specificity of the antibody action were performed with isotype-matching unrelated IgG or BSA, which were added to the chamber and preincubated with mitochondria for the same period as in case of the anti-Cx43 antibody. The effect of an unrelated monoclonal mouse IgG, taken at a two times higher protein concentration than the anti-Cx43 antibody used in Fig. 2 , was checked on Cbxactivated PTP induction (Fig. 3) . As seen in Fig. 3A , addition of IgG (trace 3) to RBM suspension did not alter the threshold calcium concentration and lag time before PTP opening in comparison with control (trace 1). Moreover, IgG was not effective in preventing the Cbx-stimulated PTP induction (compare traces 2 and 4). The monitored membrane potential was found to be similar in control conditions and in the presence of IgG (Fig. 3B, traces 1 and 3) . The Cbx-dependent decline in ⌬⌿ M was not prevented by IgG (Fig. 3B, traces 2  and 4) . Figure 3C gives the statistical analysis of the effect of IgG on the influence of Cbx in RBM. RBM treated with IgG behaved like control RBM. The Ca 2ϩ uptake rate after the second Ca 2ϩ pulse (V Ca2ϩ in.2 ), which was reduced by Cbx, was not increased again in the presence of IgG in Cbx-treated RBM. Compared with Cbx-treated mitochondria, the lag time was also not increased in the presence of Cbx and IgG. Thus, the decrease of V Ca2ϩ in.2 as well as lag time caused by Cbx was Fig. 2 . Effect of anti-connexin43 (Cx43) antibody on Cbxenhanced PTP opening in RBM. The monoclonal anti-Cx43 antibody (clone 2/connexin-43; BD Biosciences) at 1:250 dilution, which corresponds to 1 g antibody protein/mg mitochondrial protein, was used. RBM and anti-Cx43 antibody were preincubated for 10 min at 4°C with subsequent 3-min incubation in the chamber at 25°C. After that, Cbx was added and then Ca 2ϩ was added to the chamber to initiate PTP opening (as in Fig. 1 not restored in the presence of IgG, which indicates specificity of the preventive effect of the anti-Cx43 antibody.
Mitochondrial localization and phosphorylation status of Cx43 in total RBM under different conditions. The results described above suggest that Cx43 might be present in RBM. To examine the localization of Cx43 in mitochondria, submitochondrial fractions were isolated from RBM (outer membrane, intermembrane space, and mitoplasts, containing the inner membrane with matrix). The purity of mitochondrial subfractions was checked with antibodies for specific marker proteins of the outer membrane (VDAC), intermembrane space (cytochrome c), the inner membrane (COX), and matrix (SOD-2), as we reported previously (18) . The Western blot of the mitochondrial subfractions from RBM in Fig. 4A demonstrates that Cx43 is indeed present in RBM. In the subfractions of the mitochondria, Cx43 is mainly detected in the mitoplast/inner mitochondrial membrane fraction and to a lesser extent in the outer membrane fraction, but cannot be found in the intermembrane space. A similar distribution of Cx43 in mitochondrial subfractions from cultured rat astrocytes was observed ( Fig.  S3 ; Supplemental Material for this article is available online at the Journal website).
It was earlier shown that Cx43 is differentially phosphorylated. Several forms of Cx43 can be distinguished by their different electrophoretic mobility in SDS-PAGE, including the faster migrating nonphosphorylated form and slower migrating phosphorylated forms (22) . Both nonphosphorylated and phosphorylated forms of Cx43 were present in the mitoplast fraction, as evidenced by the occurrence of faster and slower migrating bands (Fig. 4A) . In the outer membrane compartment, however, mainly nonphosphorylated Cx43 was revealed, as can be seen by the fast migrating band.
Cx43 in mitochondria of cardiomyocytes is known to be phosphorylated (9, 19 ). Moreover, the phosphorylation level of serine 368 of Cx43 is intimately connected to physiological functions of Cx43 (26) . Thus, we investigated whether the different physiological conditions analyzed in our experiments, such as the challenge with threshold calcium concentration and exposure to Cbx, might modulate the level of phosphorylation of Cx43 at serine 368 in RBM. We analyzed the mitochondria by SDS-PAGE and Western blotting. Western blots of RBM with the treatments indicated in Fig. 4B were stained with anti-phospho(Ser368)Cx43 and anti-nonphospho(Ser368)Cx43 antibodies. For loading control, polyclonal anti-VDAC (porin) antibodies were used.
It is obvious from Fig. 4B , top, and the quantitative analysis in Fig. 4C that, in RBM under control conditions as well as in Cbx-treated RBM without calcium addition, a considerable fraction of Cx43 was phosphorylated. Induction of PTP opening by calcium overload evoked a significant decrease in the level of serine 368-phosphorylated Cx43 both in control and in Cbx-treated RBM. The decrease was ϳ40% (Fig. 4C) . On the other hand, the signal of the anti-nonphospho(Ser368)Cx43 antibody was only slightly changed (Fig. 4B, middle) . Thus, a decreased phosphorylation status of Cx43 at Ser368 in RBM was found in the presence of threshold calcium concentrations, which was comparable in the absence or presence of Cbx.
Synaptic and nonsynaptic mitochondria: calcium sensitivity and effect of Cbx and anti-Cx43 antibody on parameters of PTP opening. Accumulating data demonstrate mitochondrial heterogeneity within the central nervous system and differences in mitochondrial populations with regard to Ca 2ϩ capacity and threshold [Ca 2ϩ ] leading to PTP opening (11) . Taking into consideration that RBM contained both nonsynaptic and synaptic mitochondria, we determined the effect of Cbx on each kind of mitochondria, to evaluate whether both types of mitochondria obtained after separation of total RBM on the Percoll density gradient are similarly affected by Cbx. Synaptic and nonsynaptic mitochondria obtained after Percoll gradient were tested for purity by electron microscopy and Western blot, and no additional inclusions could be found in the mitochondrial samples (Supplemental Fig. S2 ). We checked the calcium retention capacity in both types of mitochondria. According to Brown and coworkers (11) , the population of synaptic mitochondria buffers less Ca 2ϩ before undergoing permeability transition than the nonsynaptic mitochondria. We added Ca 2ϩ to suspensions of mitochondria in the chamber by small bolus additions [50 M of Ca 2ϩ per addition (corresponding to 50 nmol Ca 2ϩ /mg protein)] to estimate the Ca 2ϩ threshold concentration (or Ca 2ϩ retention capacity) for each kind of mitochondria. Supplemental Fig. S5A shows that there was a significantly higher amount of Ca 2ϩ taken up by non- synaptic mitochondria before induction of PTP was observed, in comparison with synaptic mitochondria. After eight additions of Ca 2ϩ to nonsynaptic mitochondria and after four additions of Ca 2ϩ to synaptic mitochondria, rapid and complete accumulation of Ca 2ϩ into the mitochondrial matrix was observed. Each pulse was accompanied by a transient depolarization and restoration of ⌬⌿ M , as shown by the TPP ϩ trace (Supplemental Fig. S5B) . Addition of the last pulse of Ca 2ϩ , the ninth to nonsynaptic mitochondria and the fifth pulse of Ca 2ϩ to synaptic mitochondria, resulted in a decreased rate of Ca 2ϩ influx, which was correlated with membrane potential decrease. After a rather short time of retaining Ca 2ϩ , rapid Ca 2ϩ efflux from the mitochondrial matrix ensued. This efflux was associated with complete ⌬⌿ M dissipation. The results indicate that the two populations of mitochondria, synaptic and nonsynaptic, show different sensitivity to Ca 2ϩ overload, in agreement with Brown et al.'s data (11) .
Therefore, we used synaptic and nonsynaptic mitochondria to evaluate the effects of Cbx and the anti-Cx43 antibody on PTP activation by simultaneous registration of Ca 2ϩ flux and membrane potential change under threshold Ca 2ϩ load. Figure 5 , A and B, shows the effect of 1 M Cbx on initiation of PTP opening after the second calcium addition in synaptic mitochondria. Cbx was revealed to shorten the lag time before PTP opening and to accelerate the Ca 2ϩ -induced Ca 2ϩ release (trace 2) in comparison with control conditions (compare traces 1 and 2 in Fig. 5A ). Cbx-stimulated induction of PTP was CsA-sensitive (not shown) as described above for total RBM. Pretreatment of synaptic mitochondria with the monoclonal anti-Cx43 antibody from Becton-Dickinson in the same way as done with RBM (see Fig. 2 ) had no influence on control mitochondria (Fig. 5, A and B, compare traces 1 and 3) , but abolished the stimulatory effects of Cbx on Ca 2ϩ -induced PTP opening, retaining calcium in the matrix and slowing down the calcium efflux as well as dissipation of the membrane potential (Fig. 5, A and B, compare traces 2 and 4) . Thus, the anti-Cx43 antibody was able to prevent the depolarization caused by Cbx (see traces 2 and 4), allowing us to suggest that in synaptic mitochondria the effect of Cbx is linked to Cx43.
It should be noted that, under our conditions, 1 M Cbx had no significant effect on nonsynaptic mitochondria (data not shown), but Cbx was detected to be active on nonsynaptic mitochondria at 2.5 M (Fig. 5, E and F) . Therefore, we compared the effect of 2.5 M Cbx on both synaptic and After incubation with gentle shaking for 3 min, 400 nmol Ca 2ϩ /mg protein (PTP) were added and samples were incubated for 7 min. Western blot membranes were stained with polyclonal rabbit anti-phospho(Ser368)Cx43 (AB3841, Millipore, 1:1,000) and monoclonal mouse anti-nonphospho(Ser368)Cx43 (13-8300, Invitrogen, 1:500). As a loading control, polyclonal rabbit anti-VDAC antibody (1:4,000) was used. VDAC, voltage-dependent anion channel. C: quantitation of the Western blots for determining Cx43-serine 368 phosphorylation level. Data are expressed as means Ϯ SD from 3 experiments done in duplicate or triplicate. Values for mitochondria in the absence of Ca 2ϩ and Cbx were set to 100% (control.) Relative levels of phosphorylated bands were compared using Student's t-test. *P Ͻ 0.05, **P Ͻ 0.001, significantly different vs. control. nonsynaptic mitochondria. Figure 5 , C and D, shows that, at 2.5 M, Cbx exhibits a strong effect on synaptic mitochondria (compare trace 2 in Fig. 5, A and C) . After the second Ca 2ϩ addition, Ca 2ϩ release was observed in synaptic mitochondria with a very short lag time. Such fast Ca 2ϩ efflux (Fig. 5C, trace  2) was not fully suppressed by the anti-Cx43 antibody (Fig. 5C,   trace 4 ). In the presence of 2.5 M Cbx and the anti-Cx43 antibody, Ca 2ϩ was accumulated after the second addition, but the lag time was two times shorter than under control conditions. Dissipation of the membrane potential in synaptic mitochondria in the presence of 2.5 M Cbx was also faster (Fig.  5D , trace 2) than with 1 M Cbx (Fig. 5B, trace 2) , and there was only some partial repolarization of the membrane potential found in the presence of anti-Cx43 antibody (Fig. 5D, trace 4) .
The effect of 2.5 M Cbx on nonsynaptic mitochondria (Fig.  5, E and F) significantly differed from that on synaptic mitochondria. Stimulation of Ca 2ϩ release in the presence of 2.5 M Cbx was weaker than in synaptic mitochondria (compare Fig. 5, C and E, trace 2) . The inhibitory effect of the anti-Cx43 antibody, seen with synaptic mitochondria, was not observed with nonsynaptic mitochondria (compare Fig. 5, C and E,  traces 2 and 4, respectively) . In nonsynaptic mitochondria, the first Ca 2ϩ addition in the presence of 2.5 M Cbx caused a smaller depolarization (Fig. 5F, trace 2 ) in comparison to synaptic mitochondria (Fig. 5D, trace 2) , and in nonsynaptic mitochondria, ⌬⌿ M was almost fully restored. The effect of Cbx on Ca 2ϩ -induced acceleration of PTP opening was CsA sensitive in both types of mitochondria (not shown).
Our results are summarized in Fig. 5 , G and H, which demonstrates the statistical analysis of the comparative analysis for synaptic and nonsynaptic mitochondria. The effect of the anti-Cx43 antibody on the influence of Cbx is displayed. The Ca 2ϩ uptake rate after the second Ca 2ϩ pulse (V Ca2ϩ in.2 ) was more strongly reduced by Cbx in synaptic mitochondria (Fig. 5G ) than in nonsynaptic mitochondria (Fig. 5H) . When mitochondria were treated with Cbx in the presence of the anti-Cx43 antibody, only in synaptic mitochondria was V Ca2ϩ in.2 again increased (Fig. 5G) , while in nonsynaptic mitochondria the anti-Cx43 antibody was not effective to increase V Ca2ϩ in.2 (Fig. 5H) . The same was observed for the parameter lag time. Only in synaptic mitochondria, the decrease in lag time caused by Cbx was restored by addition of the anti-Cx43 antibody (Fig. 5G) . Thus, we conclude that Cbx affects Cx43 mainly in synaptic mitochondria.
Influence of PTP and Cbx on phosphorylation status of Cx43 in synaptic mitochondria. Since synaptic mitochondria were found to be more sensitive than nonsynaptic mitochondria to Ca 2ϩ overload and Cbx-stimulated PTP induction (Fig. 5) , we next analyzed whether the phosphorylation status of serine 368 in Cx43 of synaptic mitochondria was altered in the presence of threshold calcium load, when PTP is opened. The phosphorylation level of Cx43 in synaptic mitochondria was also determined in the additional presence of Cbx with threshold calcium load. Samples of synaptic mitochondria were taken from the recording chamber under the conditions shown in Fig. 5 for Western blotting. The synaptic mitochondria treated with Cbx in control conditions as well as under PTP opening were stained with antibodies against phospho(Ser368)Cx43 or against nonphospho(Ser368)Cx43. Figure 6A shows that the polyclonal anti-phospho(Ser368)Cx43 antibody (dilution 1:1,000) was able to recognize the serine 368-phosphorylated band of Cx43 in synaptic mitochondria under control conditions without added calcium (lane 1). In the absence of threshold [Ca 2ϩ ], phosphorylation was slightly increased in the presence of Cbx (lane 3). With PTP opened, the level of phosphorylated Cx43 was decreased in synaptic mitochondria (Fig. 6A, lane 2) and incubation in the presence of Cbx led to a further dephosphorylation of Ser368 in Cx43 (lane 4).
In the diagram in Fig. 6C , the average semiquantitative data for the phosphorylation status of Ser368 of Cx43 are shown. The phosphorylation of Ser368 of Cx43 in synaptic mitochondria was decreased by 50% in the presence of threshold [Ca 2ϩ ] in comparison with control and was decreased by 75% in the additional presence of Cbx. However, in Cbx-treated synaptic mitochondria without added calcium, the phosphorylation of Ser368 of Cx43 was slightly increased in comparison with the control (Fig. 6C) .
The results obtained with synaptic mitochondria differ from those with total RBM under the same conditions, where we observed no differences in the phosphorylation status of Cx43 in the presence of threshold Ca 2ϩ and in the combined presence of Cbx plus Ca 2ϩ (compare Fig. 4C with Fig. 6C ). The blot in Fig. 6B shows that the level of the serine 368-nonphosphorylated form of Cx43, as determined with the respective anti-Cx43 monoclonal antibody, is increased in the presence of threshold Ca 2ϩ and more strongly increased with exposure to Ca 2ϩ together with Cbx, indicating that the level of Cx43 phosphorylation can be modulated by threshold calcium concentration and Cbx. Results of average semiquantitative data for total nonphosphorylation status of Cx43 are displayed in the diagram in Fig. 6D . The level of the nonphospho(Ser368)Cx43 in synaptic mitochondria was higher in Ca 2ϩ overload and was increased even more (ϳ2 times) in mitochondria treated additionally with Cbx (Fig. 6D) . Thus, Cx43 was dephosphorylated at serine 368 in synaptic mitochondria loaded with Ca 2ϩ under conditions of PTP opening both in the absence or presence of Cbx. Fig. 5 ) Western blot membranes were stained with polyclonal rabbit anti-phospho(Ser368)Cx43 (1:1,000) (A) and monoclonal mouse antinonphospho(Ser368)Cx43 (1:500) (B), as described in Fig. 4 . C and D: quantitation of Cx43 phosphorylation in synaptic mitochondria, with alteration in phospho(Ser368)Cx43 level (C) and level of nonphospho(Ser368)Cx43 (D) under the indicated conditions. Data are expressed as means Ϯ SD from 3 independent experiments performed in triplicate with samples of mitochondria isolated at different days. Relative levels of phosphorylated bands were compared using Student's t-test. *P Ͻ 0.05, **P Ͻ 0.001; * and ** above columns indicate significance level vs. control.
Effect of Cbx on parameters of PTP opening and respiration in RLM.
The effect of Cbx on Ca 2ϩ fluxes in RLM was not investigated in the study by Salvi and coworkers (37) reporting the induction of PTP by Cbx (10 M) in liver mitochondria. Therefore, we included RLM in our study. The effect of Cbx on isolated RLM is displayed in Fig. 7 . We observed that, in RLM treated with 1 M Cbx, the Ca 2ϩ uptake rate (V Ca2ϩ in.2 ) was decreased in comparison with control RLM (Fig. 7A,  traces 1 and 2 ). There were no differences in Ca 2ϩ accumulation after two additions of Ca 2ϩ (60 M each) between CsA-treated control (Fig. 7A, trace 3) and CsA plus Cbxtreated RLM (Fig. 7A, trace 4) .
It should be noted that RBM (Fig. 1) and RLM (Fig. 7) have different sensitivity to calcium, which results in different threshold Ca 2ϩ concentrations. The latter is determined experimentally for each type of mitochondria. That is the reason why different amounts of Ca 2ϩ were added into the chamber for inducing the PTP opening in different types of mitochondria.
The Ca 2ϩ retention (lag time) differed significantly between control RLM and Cbx-treated RLM. The lag time was ϳ5 min for control RLM (Fig. 7A, trace 1 ) and ϳ2 min for Cbx-treated RLM (Fig. 7A, trace 2) . Thus, Cbx treatment in RLM accelerated the Ca 2ϩ release, leading to a 2.5-times shorter lag time. Registration of ⌬⌿ M in the same preparations of RLM is shown in Fig. 7B . After the second Ca 2ϩ addition, Ca 2ϩ -induced decline in ⌬⌿ M , was observed in both control (Fig.  7B, trace 1) and Cbx-treated RLM (trace 2), which was accompanied by inhibition of Ca 2ϩ uptake (Fig. 7A) . Indeed, we detected a complete dissipation of ⌬⌿ M , starting at 300 s after the second pulse of Ca 2ϩ . In the presence of 1 M Cbx, the lag time before opening of the PTP was shortened to 120 s (Fig. 7B ). Also at a concentration of 0.5 M, but not at lower concentrations, Cbx decreased the lag time for Ca 2ϩ efflux (data not shown). In the presence of CsA, no dissipation of ⌬⌿ M was observed (Fig. 7B, traces 3 and 4) , confirming that ⌬⌿ M dissipation was connected with opening of the PTP. Respiration of RLM was also measured under the same conditions. The respiration rate was not altered in state 2 (V O2 st.2 ) by Cbx (Fig. 8C, traces 1 and 2) , in contrast to RBM.
To get an additional argument supporting the notion that PTP is involved, we tried to find out whether Ca 2ϩ -induced swelling of RLM correlated with the ⌬⌿ M decrease. Therefore, we examined the influence of Cbx on swelling of isolated RLM, measuring the decrease of light scattering at 540 nm (Fig. 7C) . The swelling was initiated by addition of 75 M Ca 2ϩ to RLM (0.5 mg protein/ml) incubated in standard medium (see MATERIALS AND METHODS). Ca 2ϩ -induced swelling of RLM (Fig. 7C, trace 2) was accelerated in the presence of 1 M Cbx (trace 3) and was further enhanced in the presence of 10 M Cbx (trace 4). Cbx-stimulated acceleration of swelling of RLM was CsA sensitive (not shown). The diagram in Fig. 7D shows the average half-time (T 1/2 ) for reaching 50% of the maximal swelling of RLM. The parameter T 1/2 strongly decreases with increasing the Cbx concentration.
Lack of effect of anti-Cx43 antibody on Cbx-stimulated PTP opening in RLM. Above we showed that anti-Cx43 antibody abolished the Cbx-induced facilitation of PTP opening in RBM. A similar experiment using the anti-Cx43 antibody was performed with RLM to find out whether Cx43 might be a target of Cbx also in RLM. The result is displayed in Fig. 8 . Here we used higher amount of calcium addition for induction of PTP opening (100 M) to get a clearer difference between Cbx-treated and control mitochondria. In Cbx-treated RLM, after the second Ca 2ϩ addition, we observed accelerated Ca and 2). Depolarization of the inner membrane of Cbx-treated RLM correlated with accelerated Ca 2ϩ efflux in the presence of threshold Ca 2ϩ , having a very short Ca 2ϩ retention time (lag time). Both in the absence and in the presence of anti-Cx43 antibody, we observed a Cbx-enhanced Ca 2ϩ efflux (Fig. 8A,  traces 2 and 4) , ⌬⌿ M dissipation (Fig. 8B, traces 2 and 4) , and no reduction in state 2 respiration (Fig. 8C, traces 2 and 4) .
A quantitative analysis of the experiments investigating the influence of anti-Cx43 antibody in RLM is displayed in Fig.  8D . The statistical analysis shows that RLM treated with anti-Cx43 antibody behaved like control RLM. In RLM the decrease of V Ca2ϩ in.2 as well as of the lag time caused by Cbx was not restored in the presence of anti-Cx43 antibody, as we observed above in RBM (compare Figs. 2 and 8) . Thus, Cx43 is not a target for Cbx in RLM.
Western blot analysis of Cx43, Cx32, and Cx26 in RBM, RLM, and RHM. Cx43 was found earlier in heart mitochondria (9, 19, 32, 34) , and we detected Cx43 in total RBM in the outer and inner membranes (Fig. 4A) . Since there were significant differences in the effects of Cbx and the anti-Cx43 antibody on the Ca 2ϩ -induced PTP opening within synaptic and nonsynaptic mitochondria (Fig. 5) , we checked the relative distribution of Cx43 in synaptic and nonsynaptic mitochondria. Figure 9A shows that Cx43, which is found in total RBM, is unevenly distributed within the two populations of mitochondria. Cx43 is mainly located in synaptic mitochondria. In nonsynaptic mitochondria the Cx43 signal was very weak. We also investigated the presence of synaptotagmin I and COX by Western blot in the same samples. Figure 9A (middle and bottom) shows that synaptotagmin I is absent in samples of synaptic and nonsynaptic mitochondria, while comparable amounts of COX were found. For further details on the purity of the mitochondrial preparations, see Supplemental Fig. S2 .
For comparison, we analyzed the expression of Cx43 in RLM and rat heart mitochondria (RHM). In RHM, we detected faint bands for Cx43 (Fig. 9B, top) . Additional results of Cx43 occurrence in RHM are displayed in the online supplement (Figs. S3 and S4 ). In addition, serine 368-phosphorylated Cx43 and serine 368-nonphosphorylated Cx43 were identified in heart mitochondria (Supplemental Fig. S4 ), indicating tissue specificity of Cx43 phosphorylation. There are reports showing that in heart from different species, mitochondrial Cx43 exists mainly in the phosphorylated forms, indicating that phosphorylation can play an important role in the function of Cx43 in heart mitochondria (9, 19, 32, 34) .
In RLM, however, Cx43 was not detected (Fig. 9B, top) . This corresponds to data obtained by Kadle and coworkers (22) , who found neither binding of a specific anti-Cx43 antibody in Western blot of liver extract nor a Cx43 signal on Northern blot analysis of total RNA from liver. In addition, Beyer et al. (8) showed that anti-Cx43 antibody was able to stain gap junctions of isolated rat heart membranes but did not react with liver gap junctions.
Since we revealed the absence of Cx43 in RLM, we supposed that probably another kind of connexin might be involved in Cbx-induced induction of PTP in RLM. Therefore, we checked the existence of other types of connexins in this type of mitochondria. We used antibodies against Cx26 and Cx32. Connexins Cx26 and Cx32 are known to be highly expressed in liver (43) . Figure 9B (bottom) shows that Cx26 is present only in RLM. Cx26 was not revealed in RHM and RBM, demonstrating tissue specificity. The presence of Cx32 was demonstrated by anti-Cx32 antibody (Fig. 9B, middle) . We detected Cx32 both in RHM and RLM. Cx32 was discovered in total RBM samples before separation on Percoll density gradient (Fig. 9B, middle) but not in synaptic and nonsynaptic mitochondria (data not shown). In RBM, Cx32 was not discovered at the level of its monomer (molecular mass of ϳ32 kDa) but was seen as a dimer [ϳ51 kDa, as reported by others (17, 31) ], whereas in RLM and RHM we found mainly the Cx32 monomer and only a small amount of dimer.
DISCUSSION
Here, we assessed, for the first time, in a comparative manner the effect of Cbx on functions of isolated RBM and RLM. We found that the gap junction blocker Cbx facilitates PTP opening in RBM and RLM. The threshold for Cbx was 0.5 M in RLM and 0.1 M in RBM to shorten the lag time (lowering the capacity to retain calcium in the matrix) and to initiate the Ca 2ϩ efflux. This demonstrates a higher efficiency of Cbx in RBM. Since RBM are heterogeneous mitochondria, these RBM were separated into synaptic and nonsynaptic mitochondria. In agreement with previous findings (11), nonsynaptic mitochondria were more resistant to Ca 2ϩ -induced PTP than were synaptic mitochondria. We found that synaptic mitochondria were more sensitive to Cbx. Earlier, it was reported for RLM that 10 M Cbx causes swelling, ⌬⌿ M collapse, peroxide generation, sulphydryl oxidation, and pyridine nucleotide oxidation (37) . However, in that study the target for Cbx was not identified.
In all mitochondria tested, synaptic and nonsynaptic RBM, as well as RLM, the Cbx-stimulated Ca 2ϩ efflux was CsA sensitive, indicating the involvement of the PTP (7, 20, 44) . The exact composition of the PTP as well as the mechanisms underlying PTP formation and regulation are still not understood (27) . Nevertheless, it is obvious that PTP and modulation of PTP play an important role in delayed neurodegeneration and thus represent valuable targets for protective intervention (5, 29) .
Our study revealed that Cbx may target Cx43 in rat brain synaptic mitochondria. That conclusion is based on the facts that anti-Cx43 antibody clearly suppressed the enhancement by Cbx of the PTP opening in RBM (Fig. 2) , in synaptic mitochondria (Fig. 5G ), but not in nonsynaptic RBM (Fig. 5H) , and also not in RLM (Fig. 8) . We detected Cx43 in brain mitochondria, mostly in synaptic mitochondria, but in nonsynaptic mitochondria to a low degree, and in RLM Cx43 not at all by Western blot. These findings are in accordance with the fact that, in RLM, the anti-Cx43 antibody was not able to prevent the Cbx-dependent acceleration of PTP opening. We employed two different monoclonal anti-Cx43 antibodies directed against a peptide covering amino acids 252 to 270 of rat Cx43. Since Cx43 was found in the outer and in the inner membrane of RBM, like in heart mitochondria (9, 19, 32, 34) , we consider that part of Cx43 located on the outer membrane would have the ability to react with anti-Cx43 antibody. Experiments with rat cardiomyocyte mitochondria revealed that the COOH terminus of Cx43 is oriented toward the intermembrane space (30) . Interestingly, the epitope that the monoclonal antibody, which was effective in our functional studies (Figs. 2 and 5), recognizes is within this COOH-terminal region.
Previously, Salvi et al. (37) reported that the effect of Cbx in RLM is related to ROS production and interaction with the electron transport chain at the level of complex I and complex III. We examined Cbx-induced ROS production in RBM. However, in RBM the level of H 2 O 2 was rather low in the presence of threshold calcium concentration. Moreover, generation of H 2 O 2 by RBM was not enhanced in the presence of 1 M Cbx (Supplemental Fig. S1, A and B) . In RLM, we found only a small ROS formation in the presence of Cbx (Supplemental Fig. S1C ). In addition, two ROS scavengers, N-acetylcysteine (2 mM) and resveratrol (40 M), were used to check possible prevention of the Cbx-stimulated induction of PTP in RBM. However, neither of these scavengers had any effect on PTP induction (data not shown).
Cx43 was not found in liver tissue (22) . Thus, we supposed that the Cbx-induced activation of PTP opening in RLM could be due to other types of connexins, particularly Cx32 or Cx26. In the present study, for the first time, Cx26 was found in RLM. However, we did not discover Cx26 in RBM and RHM. This is in accordance with previous analysis of tissue distribution of connexins (43) . There it was established by Northern blotting that Cx26 and Cx32 were coexpressed in liver but absent in heart. Here, Cx32 protein was also revealed in RLM and RHM.
Cx43 in mitochondria of cardiomyocytes is known to be phosphorylated (9, 19, 32, 34) , but it is not exactly clear which amino acid residues are phosphorylated. One important phosphorylation site in Cx43 is serine 368 in the COOH terminus, which is phosphorylated by protein kinase C. Here, we found that PTP and Cbx modulate the phosphorylation status of Cx43 on serine 368 in total RBM and in synaptic mitochondria. Cx43 was dephosphorylated on serine 368 in the presence of threshold [Ca 2ϩ ], leading to PTP opening. The phosphorylation level of Cx43 was also significantly decreased in synaptic mitochondria cotreated with Ca 2ϩ plus Cbx, where pore opening was accelerated. Thus, we suggest that Cbx might regulate mitochondrial functions by modulating the phosphorylation of serine 368 and possibly modifying the conductance of the Fig. 9 . Distribution of Cx43, Cx32, and Cx26 in RBM, RLM, and rat heart mitochondria (RHM). A: RBM were further separated in synaptic and nonsynaptic mitochondria. Western blot analysis of Cx43 with the monoclonal mouse anti-Cx43 antibody (Becton-Dickinson, dilution 1:1,000) was performed. Purity and loading control of the mitochondrial fractions were analyzed by staining with antibodies for synaptotagmin I (1: 10,000) and cytochrome-c oxidase (COX; 1:4,000) B: detection of Cx43, Cx26, and Cx32 in mitochondria from different rat tissues. RBM, RHM, and RLM were separated on SDS-PAGE followed by Western blot analysis. The membranes were stained for the presence of Cx43 (top) using the monoclonal anti-Cx43 antibody (dilution 1:1,000); for Cx32 (middle) using an anti-Cx32 monoclonal antibody (dilution 1:2,000); and for Cx26 (bottom) using an anti-Cx26 monoclonal antibody (dilution 1:500). In accordance with the data sheet from the supplier and as reported in Refs. 17 and 31, the Cx32 antibody reacts with both the monomeric and the dimeric forms of Cx32 (molecular mass of ϳ32 kDa and 51 kDa, respectively).
Cx43 channel. The latter suggestion is based on reports showing that phosphorylation of serine 368 leads to a change in the function of Cx43, by increasing the frequency of the lowconductance state and decreasing the frequency of the fully open state of the channel (26) .
Whether the mitochondrial functions of Cx43 have to do with its gap junction property is still under debate (15, 21) . Comparing astrocytes from wild-type animals and from connexin43-null mice, it was reported during preparation of this work that Cx43 is involved in K ϩ sequestration in astrocyte mitochondria. The authors concluded that mitochondria play a key role in cytosolic K ϩ handling in astrocytes by employing Cx43, besides the mitochondrial ATP-sensitive K ϩ channels (24) .
We propose the following hypothesis for the functional implications of our findings. We show that blockage of Cx43 by Cbx accelerates PTP opening, which exacerbates neural cell death. Thus, we conjecture that activity of Cx43 in mitochondria could exert neuroprotection. This interpretation is in line with the proposal made for heart mitochondria, where it was suggested that Cx43 contributes to cytoprotection (33) via mitochondrial K ϩ flux (30) , as well as to ischemic preconditioning (9, 32, 34) . In conclusion, we suggest that Cx43 plays an apparent role in modulation of neural cell death connected with Ca 2ϩ dysregulation and in neuroprotection in different neuropathological conditions.
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